tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

APGE Stock Latest News

Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit
Press ReleasesApogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit
8d ago
APGE
Apogee Therapeutics names Jeff Hartness as Chief Commercial Officer
PremiumThe Fly
Apogee Therapeutics names Jeff Hartness as Chief Commercial Officer
11d ago
APGE
Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer
PremiumPress Releases
Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer
11d ago
APGE
Wedbush bullish on Spyre Therapeutics, initiates with an Outperform
PremiumThe Fly
Wedbush bullish on Spyre Therapeutics, initiates with an Outperform
16d ago
APGE
SYRE
Apogee Therapeutics Begins Landmark Atopic Dermatitis Trial
PremiumCompany Announcements
Apogee Therapeutics Begins Landmark Atopic Dermatitis Trial
1M ago
8K
APGE
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
PremiumPress ReleasesApogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
1M ago
APGE
Apogee announces first participants dosed in Phase 1 trial of APG990
Premium
The Fly
Apogee announces first participants dosed in Phase 1 trial of APG990
1M ago
APGE
Apogee Therapeutics files automatic mixed securities shelf
Premium
The Fly
Apogee Therapeutics files automatic mixed securities shelf
1M ago
APGE
Morning Movers: KeyCorp surges following Scotiabank taking stake
PremiumThe Fly
Morning Movers: KeyCorp surges following Scotiabank taking stake
1M ago
HE
CYD
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results
PremiumPress Releases
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results
1M ago
APGE
Apogee Therapeutics reports Q2 net loss $33.8M vs. $18.9M last year
PremiumThe Fly
Apogee Therapeutics reports Q2 net loss $33.8M vs. $18.9M last year
1M ago
APGE
NewAmsterdam Pharma appoints McKenna, Joustra to board of directors
PremiumThe Fly
NewAmsterdam Pharma appoints McKenna, Joustra to board of directors
2M ago
APGE
NAMS
Top Stock Gainers Today – LNTH, APGE, and More
PremiumMarket NewsTop Stock Gainers Today – LNTH, APGE, and More
2M ago
CCJ
NXE
Apogee Therapeutics intiated with Not Rated at Goldman Sachs
Premium
The Fly
Apogee Therapeutics intiated with Not Rated at Goldman Sachs
4M ago
APGE
Apogee Therapeutics Welcomes Dr. Bollinger to Board
Premium
Company Announcements
Apogee Therapeutics Welcomes Dr. Bollinger to Board
4M ago
8K
APGE
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
PremiumPress Releases
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
4M ago
APGE
Apogee Therapeutics expands board of directors with appointment of Bollinger
PremiumThe Fly
Apogee Therapeutics expands board of directors with appointment of Bollinger
4M ago
MRK
APGE
Apogee Therapeutics to Participate in Upcoming June Investor Conferences
PremiumPress Releases
Apogee Therapeutics to Participate in Upcoming June Investor Conferences
4M ago
APGE
Apogee Therapeutics Starts Phase 2 Trial for Atopic Dermatitis Drug
PremiumCompany Announcements
Apogee Therapeutics Starts Phase 2 Trial for Atopic Dermatitis Drug
4M ago
8K
APGE
Apogee doses 1st patient in atopic dermatitis trial of IL-13 antibody APG777
PremiumThe FlyApogee doses 1st patient in atopic dermatitis trial of IL-13 antibody APG777
4M ago
APGE
Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
Premium
Press Releases
Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
4M ago
APGE
Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
Premium
Press Releases
Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
4M ago
APGE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >